Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Expands By 15.8%

Health Catalyst, Inc. (NASDAQ:HCAT) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 15.8% from the March 31st total of 1,520,000 shares. Based on an average daily trading volume, of 616,300 shares, the days-to-cover ratio is presently 2.9 days.

Hedge Funds Weigh In On Health Catalyst

Several institutional investors have recently modified their holdings of the business. Nepsis Inc. increased its position in shares of Health Catalyst by 20.5% in the 4th quarter. Nepsis Inc. now owns 1,091,932 shares of the company’s stock valued at $10,111,000 after purchasing an additional 186,128 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Health Catalyst by 124.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company’s stock worth $8,652,000 after acquiring an additional 473,323 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Health Catalyst by 1.2% in the third quarter. Vanguard Group Inc. now owns 6,441,707 shares of the company’s stock valued at $65,190,000 after purchasing an additional 78,823 shares in the last quarter. MQS Management LLC acquired a new position in shares of Health Catalyst in the 3rd quarter valued at $116,000. Finally, American Century Companies Inc. grew its position in shares of Health Catalyst by 10.4% in the 3rd quarter. American Century Companies Inc. now owns 657,552 shares of the company’s stock valued at $6,654,000 after buying an additional 62,010 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on HCAT shares. Cantor Fitzgerald restated an “overweight” rating and issued a $16.00 target price on shares of Health Catalyst in a research report on Wednesday, April 10th. Canaccord Genuity Group decreased their target price on shares of Health Catalyst from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Friday, February 23rd. Evercore ISI cut their price target on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Guggenheim upgraded Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price objective on the stock in a research report on Friday, January 26th. Finally, Piper Sandler reissued an “overweight” rating and issued a $15.00 price objective (down previously from $17.00) on shares of Health Catalyst in a report on Friday, February 23rd. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $12.10.

Health Catalyst Trading Up 5.1 %

Shares of HCAT traded up $0.31 during midday trading on Monday, hitting $6.34. 926,109 shares of the stock were exchanged, compared to its average volume of 620,095. Health Catalyst has a 52-week low of $5.45 and a 52-week high of $14.37. The company has a debt-to-equity ratio of 0.62, a quick ratio of 4.42 and a current ratio of 4.42. The stock has a fifty day simple moving average of $7.39 and a 200 day simple moving average of $8.25. The firm has a market cap of $371.27 million, a P/E ratio of -3.02 and a beta of 1.29.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Thursday, February 22nd. The company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. The company had revenue of $75.08 million during the quarter, compared to analysts’ expectations of $73.67 million. On average, research analysts anticipate that Health Catalyst will post -0.47 EPS for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.